Haemophilia-header

Expansion of data transfer from Thailand Hereditary Bleeding Disorders Registry to the AGS

This month, an article was published in Haemophilia, the official journal of the World Federation of Hemophilia (WFH), covering the concept of data transfer from the Thailand Hereditary Bleeding Disorders Registry (HBDR) to the WFH Annual Global Survey (AGS).

Also available in: Français Español

The Thai Society of Haematology (TSH) initiated the HBDR in 2018, and hemophilia treatment centres (HTCs) in Thailand have been entering patients’ medical record data in the system since 2020. In 2021, the HBDR started collaborating with the WFH to integrate data into the WFH World Bleeding Disorders Registry (WBDR)—the only global registry for collecting standardized clinical data on people with hemophilia (PWH) and people with von Willebrand disease (VWD). Since 2021, selected HBDR data have been successfully transferred to the WBDR annually. This development is notable because data help optimize resources for treatment, evaluate outcomes from the use of these resources, and support identifying the most promising resource applications; they are also the foundation of strong advocacy efforts.

Building on the same concept of data integration from the HBDR to the WBDR, selected HBDR data will be submitted directly from the HBDR to the National Hemophilia Foundation of Thailand—the WFH national member organization (NMO). The National Hemophilia Foundation of Thailand is responsible for submitting country level data to the WFH Annual Global Survey (AGS), contributing to a body of information that will be used by advocates and researchers around the world. Through this practice of data transfer, repetitive workload functions by the HTCs can be reduced or eliminated. In this way, the burden of data collection for both HTCs and NMO will be minimized, allowing the process to be efficient and error-free. By leveraging the use of technology, countries like Thailand can better manage their data, and can also more easily submit that data to the AGS. It is hoped that this will encourage even more countries to contribute to the survey, to the benefit of the global bleeding disorders community.

To read “Direct data transfer of people with hereditary bleeding disorders from the Thai haemophilia treatment centre registry to the Annual Global Survey of the World Federation of Hemophilia”, please click here.

To find out more about the WFH Annual Global Survey (AGS), click here. To find out more about the WFH World Bleeding Disorders Registry (WBDR), click here.

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.